Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy is a research paper published in Best Practice & Research Clinical Endocrinology & Metabolism (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NEI NIH HHS
Grant: R01 EY008976
NIAID NIH HHS
Grant: UM1 AI144298
NEI NIH HHS
Grant: R01 EY011708
NEI NIH HHS
Grant: F32 EY007002
NIDDK NIH HHS
Grant: R01 DK063121
NIAID NIH HHS
Grant: UM1 AI110557
NEI NIH HHS
Grant: P30 EY007003
National Institutes of Health
FWCI
1.48
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals